Press Releases from Creative Biolabs (6 total)
Exosome Display Technology for Antibody Generation, Targeted Delivery, and Prote …
Scientists now have realized that exosomes, representing a novel mode of intercellular communication, contribute to a wide range of biological processes in health and disease including cancer. Especially, growing evidence shows that tumor-derived exosomes play critical roles in cancer. Exosomes and their cargos may serve as cancer prognostic markers, therapeutic targets or even as anticancer drug‐carrier.
Exosome display is an innovative methodology enabling the manipulation of exosome protein content by the…
Exosomes News: Creative Biolabs Introduces Exosome Purification Services for Car …
As exosomes can transmit the information of donor cells to recipient cells through the proteins, mRNA, miRNA carried by them, thus to realize the information and material exchange between cells, they have been a hot topic recently as being used as a drug carrier to transport drugs.
"Future research may focus on how to improve the cargo loading of exosomes," said the senior scientist from Creative Biolabs, “at present, some…
Creative Biolabs Upgrades Oncolytic Virus Product List for Immunotherapy Researc …
As early as around 1800, doctors discovered that certain cancer patients would have their symptoms reduced after being briefly infected with viruses. With the advancement of genetic engineering technology, the idea that viruses have the potential to improve and mediate immunotherapy has been established. Oncolytic viruses (OVs) are such kind of viruses that can replicate in tumor tissues, and kill tumor cells. Up to now, two OV drugs have been…
Novel Strategies to Accelerate Research on Antibodies Against Exosomal Markers
Exosome, with a lipid bilayer membrane structure, is a tiny membrane vesicle that can be secreted by most cells. As a new research hotspot, exosomes have become a potentially effective method for disease diagnosis and treatment due to their wide existence in the body and convenient access, and have shown great potential in exosomal cargo loading and targeted delivery. Additionally, research on exosome antibodies may contribute to shaping the future…
Creative Biolabs Unveils One-stop Solutions of CAR-macrophage Therapy Developmen …
Chimeric antigen receptor (CAR) T cell therapy has been a hot topic in tumor treatment for several years, and as it encounters challenges in solid tumors, such as poor penetration of T cells into tumors, CAR macrophage therapy turns up to be a novel therapy aiming to enhance the ability of CAR cells to attack solid tumors.
Since being founded in 2004, Creative Biolabs has accumulated a wealth of experience in…
Creative Biolabs Updates Antibody Catalog for COVID-19 Research
The SARS-COV-2 is rampaging throughout the world, posing threat to the health of human beings, hindering the economic growth of many countries, meanwhile challenging the current medical technologies. There are 16.3M confirmed cases, 649K death, and 9.41M recovered, updated on July 27, 2020. Highly infections as it is, the SARS-COV-2 transmits from person to person, through droplets produced when the infected person coughs, sneezes, or speaks, which can fall on…
